Aim of the work Impact of serum vit D level in SLE patients with COVID-19 disease on severity of infection, duration of COVID-19 disease course, fatigue development as a complication for both SLE and COVID-19 and assess impact of prior chloroquine on COVID-19 disease outcomes Patients and methods 38 SLE patients previously diagnosed and on different lines of lupus management. Participants were presented to chest outpatient clinic and emergency hospital, Mansoura University with manifestation suggesting COVID-19 infection. Serum vit D was measured in serum by ELISA.
Primary objective: assess the impact of serum vit D level in SLE patients with COVID-19 disease on severity of infection and pandemic treatment outcome. Secondary objectives: * Effect of serum vit D level in SLE patients on duration of COVID-19 disease course and fatigue development as a complication for both SLE and COVID-19 * Impact of prior chloroquine on COVID-19 disease outcomes * Correlation of serum vit D level with different laboratory investigations at time of COVID-19 outbreak
Study Type
OBSERVATIONAL
Enrollment
38
Impact of serum vit D level in SLE patients with COVID-19 disease on severity of infection, duration of COVID-19 disease course, fatigue development as a complication for both SLE and COVID-19 and assess impact of prior chloroquine on COVID-19 disease outcomes
Measure vitamin D level
Mansoura University Hospital
Al Mansurah, DK, Egypt
Level of serum vitamin D in SLE infected with COVID-19
Measurement of serum vit D level (ng/ml)
Time frame: 6 months
Vitamin D level with COVID-19 severity
Level of serum vitamin D (ng/ml) in mild, moderate and sever COVID-19
Time frame: 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.